271 related articles for article (PubMed ID: 31873802)
1. Intermittent cholecalciferol supplementation in children and teenagers followed in pediatric nephrology: data from a prospective single-center single-arm open trial.
Aurelle M; Basmaison O; Ranchin B; Kassai-Koupai B; Sellier-Leclerc AL; Bertholet-Thomas A; Bacchetta J
Eur J Pediatr; 2020 Apr; 179(4):661-669. PubMed ID: 31873802
[TBL] [Abstract][Full Text] [Related]
2. Impact of three different daily doses of vitamin D3 supplementation in healthy schoolchildren and adolescents from North India: a single-blind prospective randomised clinical trial.
Marwaha RK; Garg MK; Sethuraman G; Gupta N; Mithal A; Dang N; Kalaivani M; Ashraf Ganie M; Narang A; Arora P; Singh A; Chadha A; Manchanda RK
Br J Nutr; 2019 Mar; 121(5):538-548. PubMed ID: 30843501
[TBL] [Abstract][Full Text] [Related]
3. Annual intramuscular injection of a megadose of cholecalciferol for treatment of vitamin D deficiency: efficacy and safety data.
Diamond TH; Ho KW; Rohl PG; Meerkin M
Med J Aust; 2005 Jul; 183(1):10-2. PubMed ID: 15992330
[TBL] [Abstract][Full Text] [Related]
4. The effect of oral loading doses of cholecalciferol on the serum concentration of 25-OH-vitamin-D.
Jansen RB; Svendsen OL
Int J Vitam Nutr Res; 2014; 84(1-2):45-54. PubMed ID: 25835235
[TBL] [Abstract][Full Text] [Related]
5. [Effects of oral vitamin D
Tahar A; Zerdoumi F; Saidani M; Griene L; Koceir EA
Ann Biol Clin (Paris); 2018 Jun; 76(3):313-325. PubMed ID: 29661746
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity in serum 25-hydroxy-vitamin D response to cholecalciferol in elderly women with secondary hyperparathyroidism and vitamin D deficiency.
Giusti A; Barone A; Pioli G; Girasole G; Razzano M; Pizzonia M; Pedrazzoni M; Palummeri E; Bianchi G
J Am Geriatr Soc; 2010 Aug; 58(8):1489-95. PubMed ID: 20646099
[TBL] [Abstract][Full Text] [Related]
7. VITamin D supplementation in renAL transplant recipients (VITALE): a prospective, multicentre, double-blind, randomized trial of vitamin D estimating the benefit and safety of vitamin D3 treatment at a dose of 100,000 UI compared with a dose of 12,000 UI in renal transplant recipients: study protocol for a double-blind, randomized, controlled trial.
Courbebaisse M; Alberti C; Colas S; Prié D; Souberbielle JC; Treluyer JM; Thervet E
Trials; 2014 Nov; 15():430. PubMed ID: 25376735
[TBL] [Abstract][Full Text] [Related]
8. High-dose oral vitamin D3 supplementation in rheumatology patients with severe vitamin D3 deficiency.
von Restorff C; Bischoff-Ferrari HA; Theiler R
Bone; 2009 Oct; 45(4):747-9. PubMed ID: 19539796
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of weekly administration of cholecalciferol on parathyroid hormone in stable kidney-transplanted patients with CKD stage 1-3.
Sella S; Bonfante L; Fusaro M; Neri F; Plebani M; Zaninotto M; Aghi A; Innico G; Tripepi G; Michielin A; Prandini T; Calò LA; Giannini S
Clin Chem Lab Med; 2020 May; 59(2):343-351. PubMed ID: 32374278
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D levels in Swiss breast cancer survivors.
Baumann M; Dani SU; Dietrich D; Hochstrasser A; Klingbiel D; Mark MT; Riesen WF; Ruhstaller T; Templeton AJ; Thürlimann B
Swiss Med Wkly; 2018; 148():w14576. PubMed ID: 29376548
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D levels, vitamin D supplementation, and prognosis in patients with chronic kidney disease
.
Namir Y; Cohen MJ; Haviv YS; Slotki I; Shavit L
Clin Nephrol; 2016 Oct; 86(10):165-74. PubMed ID: 27616756
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of vitamin D deficiency and effects of supplementation with cholecalciferol in patients with chronic kidney disease.
Kim SM; Choi HJ; Lee JP; Kim DK; Oh YK; Kim YS; Lim CS
J Ren Nutr; 2014 Jan; 24(1):20-5. PubMed ID: 24216258
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of oral continuous low-dose versus short-term high-dose vitamin D: a prospective randomised trial conducted in a clinical setting.
Hackman KL; Gagnon C; Briscoe RK; Lam S; Anpalahan M; Ebeling PR
Med J Aust; 2010 Jun; 192(12):686-9. PubMed ID: 20565345
[TBL] [Abstract][Full Text] [Related]
14. Impact of two oral doses of 100,000 IU of vitamin D
Ducharme FM; Jensen M; Mailhot G; Alos N; White J; Rousseau E; Tse SM; Khamessan A; Vinet B
Trials; 2019 Feb; 20(1):138. PubMed ID: 30777118
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D insufficiency and treatment with oral vitamin D3 in children with chronic kidney disease.
Kari JA; Eldesoky SM; Bagdadi OT
Saudi Med J; 2012 Jul; 33(7):740-4. PubMed ID: 22821307
[TBL] [Abstract][Full Text] [Related]
16. Cholecalciferol (vitamin D3) therapy and vitamin D insufficiency in patients with chronic kidney disease: a randomized controlled pilot study.
Chandra P; Binongo JN; Ziegler TR; Schlanger LE; Wang W; Someren JT; Tangpricha V
Endocr Pract; 2008; 14(1):10-7. PubMed ID: 18238736
[TBL] [Abstract][Full Text] [Related]
17. Effect of vitamin D3 seasonal supplementation with 1500 IU/day in north Italian children (DINOS study).
Mazzoleni S; Magni G; Toderini D
Ital J Pediatr; 2019 Jan; 45(1):18. PubMed ID: 30691521
[TBL] [Abstract][Full Text] [Related]
18. Monthly cholecalciferol administration in haemodialysis patients: a simple and efficient strategy for vitamin D supplementation.
Jean G; Souberbielle JC; Chazot C
Nephrol Dial Transplant; 2009 Dec; 24(12):3799-805. PubMed ID: 19622574
[TBL] [Abstract][Full Text] [Related]
19. Comparison of two vitamin D supplementation strategies in children with sickle cell disease: a randomized controlled trial.
Grégoire-Pelchat P; Pastore Y; Robitaille N; LeMay S; Khamessan A; Kleiber N; Nyalendo C; Gagné N; Alos N; Mailhot G
Br J Haematol; 2021 Jan; 192(2):385-394. PubMed ID: 33169863
[TBL] [Abstract][Full Text] [Related]
20. Effect of 16-weeks vitamin D replacement on calcium-phosphate homeostasis in overweight and obese adults.
Mesinovic J; Mousa A; Wilson K; Scragg R; Plebanski M; de Courten M; Scott D; Naderpoor N; de Courten B
J Steroid Biochem Mol Biol; 2019 Feb; 186():169-175. PubMed ID: 30367939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
